Nadège Vimond

Dendritic cell-derived exosomes as maintenance immunotherapy after first line chemotherapy in NSCLC

Benjamin Besse, Mélinda Charrier, Valérie Lapierre et al. · OncoImmunology · 2015 · 782 citations · Full text

Life Sciences, Immunology, Oncology +16

A direct comparison of CellSearch and ISET for circulating tumour-cell detection in patients with metastatic carcinomas

F Farace, Christophe Massard, Nadège Vimond et al. · British Journal of Cancer · 2011 · 399 citations · Full text

Medicine, Cell Biology, Oncology +15

Immune Infiltrates Are Prognostic Factors in Localized Gastrointestinal Stromal Tumors

Sylvie Rusakiewicz, Michaëla Semeraro, Matthieu Sarabi et al. · Cancer Research · 2013 · 296 citations · Full text

Life Sciences, Immunology, Oncology +17

Anticancer immunotherapy by CTLA-4 blockade: obligatory contribution of IL-2 receptors and negative prognostic impact of soluble CD25

Dalil Hannani, Marie Vétizou, David Enot et al. · Cell Research · 2015 · 160 citations · Full text

Medicine, Immunology, Oncology +17

Efficacy, Safety, and Biomarkers of Single-Agent Bevacizumab Therapy in Patients with Advanced Hepatocellular Carcinoma

Valérie Boige, David Malka, Abderrahmane Bourredjem et al. · The Oncologist · 2012 · 133 citations · Full text

Medicine, Oncology, Pharmacology +17